BIOTRICITY INC.

BTCYSEC EDGAR

Surgical & Medical Instruments & Apparatus(NV)CIK: 1630113

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue from Contract with Customer, Excluding Assessed Tax	$12.1M	$9.6M	$7.7M	$3.4M	$1.4M
Cost of Revenue	$3.7M	$4.2M	$3.1M	$2.1M	$932.0K
Gross Profit	$8.4M	$5.4M	$4.6M	$1.3M	$485.8K
Research and Development Expense	$2.6M	$3.2M	$2.7M	$2.1M	$1.4M
Selling, General and Administrative Expense	$14.6M	$17.6M	$18.6M	—	—
Operating Expenses	$17.2M	$20.9M	$21.3M	$14.6M	$11.4M
Operating Income (Loss)	-$8.8M	-$15.4M	-$16.7M	—

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$5.9M	$6.5M	$16.7M	$4.4M	$2.0M
Assets, Current	$4.5M	$4.7M	$15.3M	$4.3M	$1.7M
Cash and Cash Equivalents, at Carrying Value	$786.1K	$570.5K	$12.1M	$2.2M	$949.8K
Accounts Receivable, after Allowance for Credit Loss, Current	$1.5M	$1.2M	$2.0M	$1.5M	$486.2K
Inventory, Net	$1.9M	$2.3M	$842.9K	$272.5K	$85.7K
Liabilities	$35.9M	$26.4M	$18.8M	$11.3M	$5.0M
Liabilities, Current	$22.7M	$11.2M	$4.9M	$10.5M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	-$6.7M	-$13.5M	-$15.2M	-$11.1M	-$7.9M
Net Cash Provided by (Used in) Investing Activities	—	—	-$29.8K	-$29.8K	—
Net Cash Provided by (Used in) Financing Activities	$6.7M	$2.0M	$25.2M	$12.2M	$8.9M
Payments to Acquire Property, Plant, and Equipment	—	—	$29.8K	$29.8K	—
Payments of Dividends	—	—	—	—	$180.0K

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)